Insights
How to Build Risk-Based Remediation Plans for GMP Compliance
For medical device companies seeking to conduct clinical trials in the United States, an Investigational Device Exemption (IDE) application is essential. A well-prepared IDE submission
Navigating FDA IDE Approval: Risk-Based Preparation and Checklist
How Long Does FDA IDE Review Take? Key Milestones Explained For medical device innovators and biotechnology companies developing diagnostic or therapeutic devices, obtaining approval to
FDA IDE Approval: Critical Elements Reviewers Evaluate
How Long Does FDA IDE Review Take? Key Milestones Explained For medical device innovators and biotechnology companies developing diagnostic or therapeutic devices, obtaining approval to
Fixing Quality System Failures After Audits: A Practical Guide
How to Develop an FDA-Inspection-Ready Quality Management System For biotech and pharmaceutical companies, regulatory inspections are not simply compliance events. They are a comprehensive evaluation
Fixing QMS Failures in Pharma: Structured Remediation Approach
How to Develop an FDA-Inspection-Ready Quality Management System For biotech and pharmaceutical companies, regulatory inspections are not simply compliance events. They are a comprehensive evaluation
GMP Technology Transfer: Compliance Requirements
Risk-Based Technology Transfer in Pharma Technology transfer in pharmaceutical manufacturing is rarely a simple handoff between development and production teams. It involves transferring complex knowledge